Sigma Healthcare

Guardian Pharmacy is taking over prescription files, pharmacy inventories and certain fixed assets of Tennessee-based Nautilus Pharmacy. Nautilus supplies assisted-living facilities by mail order in 14 US states; Guardian will transition the care of those residents to 18 local Guardian pharmacies in the respective markets. More than half of Nautilus’s employees will be retained, the regional integration will be led by David Brown, and the financial terms of the transaction have been kept confidential. » Więcej na de.investing.com

For the year to June 2026 Sigma Healthcare recorded revenue up 15.5% to AUD 10.8 billion, normalized EBIT of AUD 1.098 billion (+20.6%) and normalized NPAT of AUD 732.3 million (+22.3%). The stock fell about 6.2% as investors highlighted extended cash conversion, integration costs and margin risks from strong GLP-1 category growth. Management reports realized synergies and continued store growth; the company expects ongoing revenue momentum and plans to deliver further synergies through 2029. » Więcej na de.investing.com

Australia’s Sigma Healthcare has ended early-stage talks to acquire U.K. pharmacy chain Boots, saying the asset no longer fits its strategic priorities and it will focus on Australian and Asian growth. The withdrawal prolongs uncertainty over Boots’ ownership; the chain operates about 1,800 UK stores and has recently been repositioned toward higher-margin beauty and wellness categories. Boots’ owner Sycamore Partners is reported to be considering an IPO as alternatives to a sale continue to be explored. » Więcej na forbes.com